Found: 18
Select item for more details and to access through your institution.
Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 419, doi. 10.1007/s00280-005-0167-4
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of weekly NV06 (Phenoxodiol™), a novel isoflav-3-ene, in patients with advanced cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 427, doi. 10.1007/s00280-006-0189-6
- By:
- Publication type:
- Article
Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 434, doi. 10.1007/s00280-005-0177-2
- By:
- Publication type:
- Article
The skin and hair as surrogate tissues for measuring the target effect of inhibitors of phosphoinositide-3-kinase signaling.
- Published in:
- 2006
- By:
- Publication type:
- journal article
The tumor specific cytotoxicity of dihydronitidine from Toddalia asiatica Lam.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 451, doi. 10.1007/s00280-005-0183-4
- By:
- Publication type:
- Article
Additive antitumor effects of gefitinib and imatinib on anaplastic thyroid cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 460, doi. 10.1007/s00280-006-0185-x
- By:
- Publication type:
- Article
Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 471, doi. 10.1007/s00280-005-0184-3
- By:
- Publication type:
- Article
Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 478, doi. 10.1007/s00280-006-0186-9
- By:
- Publication type:
- Article
Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 487, doi. 10.1007/s00280-005-0178-1
- By:
- Publication type:
- Article
Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 504, doi. 10.1007/s00280-006-0200-2
- By:
- Publication type:
- Article
Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 509, doi. 10.1007/s00280-006-0191-z
- By:
- Publication type:
- Article
Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 517, doi. 10.1007/s00280-006-0199-4
- By:
- Publication type:
- Article
Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 527, doi. 10.1007/s00280-006-0198-5
- By:
- Publication type:
- Article
Pharmacokinetics of N-2-chloroethylaziridine, a volatile cytotoxic metabolite of cyclophosphamide, in the rat.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 532, doi. 10.1007/s00280-006-0196-7
- By:
- Publication type:
- Article
Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 540, doi. 10.1007/s00280-006-0197-6
- By:
- Publication type:
- Article
Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 547, doi. 10.1007/s00280-006-0195-8
- By:
- Publication type:
- Article
Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 555, doi. 10.1007/s00280-006-0204-y
- By:
- Publication type:
- Article